Abstract
Statins are currently the most prescribed drug against dyslipidemia. However, considered safe, statins are associated with several adverse effects, especially those related to myalgia, rhabdomyolysis and other muscle symptoms related to the use of statins (SMRE), which account for about 65% of cases of low adherence to treatment. This low adherence to treatment, consequently, leads to inc…